Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
COVID-19
WCG IRB’s Single-Patient Expanded Access Experience Before and During the COVID-19 Pandemic
Blog Posts
Protecting Patients, Protecting Your Study: The Benefits Of A Well-Run Data Monitoring Committee
Blog Posts
Participant Recruitment
Can you use patient Electronic Health Records to identify and recruit subjects?
Blog Posts
Site Efficiency
Using an IRB’s Site Relationships to Relieve “Site Crunch” and Reduce Trial Pressures
Blog Posts
Series: Ask the IRB & IBC Experts
Is informed consent needed for post-market patient registry?
Blog Posts
Clinical Trial Operations
The Top Five Things You Need to Know About Hosting Virtual Investigator Training
Blog Posts
Cell & Gene Therapy
Key Takeaways From FDA’s New Draft Guidance, “Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial”
Blog Posts
Participant Recruitment
Does the IRB need to approve doctor-to-doctor letters?
Blog Posts
Regulatory Compliance
What are the IRB review requirements for human factors/usability testing?
Blog Posts